Masimo
MASI
$97.94
Share price
-1.93%
Change (1 day)
-34.82%
Change (1 year)
Categories
Masimo is an American manufacturer of noninvasive patient monitoring technologies based in Irvine, California.
Operating Margin for Masimo (MASI)
Operating Margin as of September 2023 (TTM): 9.49%
According to Masimo's latest financial reports and stock price the company's current Operating Margin is 9.49%. At the end of 2022 the company had an Operating Margin of 9.50%.
Operating Margin history for Masimo from 2007 to 2006
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 9.50% | -57.1% |
| 2021 | 22.14% | -3.97% |
| 2020 | 23.06% | -7.65% |
| 2019 | 24.97% | 0.25% |
| 2018 | 24.91% | -0.29% |
| 2017 | 24.98% | -58.52% |
| 2016 | 60.23% | 226.17% |
| 2015 | 18.46% | 6.15% |
| 2014 | 17.39% | 25.7% |
| 2013 | 13.84% | -18.57% |
| 2012 | 16.99% | -13.79% |
| 2011 | 19.71% | -25.71% |
| 2010 | 26.53% | 12.72% |
| 2009 | 23.54% | -0.15% |
| 2008 | 23.57% | -11.31% |
| 2007 | 26.58% | -81.03% |
| 2006 | 140.15% | 1951.9% |
| 2005 | 6.83% | -93.17% |
| 2004 | 100.00% | -778.09% |
| 2003 | -14.75% | 3063.91% |
| 2002 | -0.47% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 14.17% | 49.32% | 🇺🇸 USA |
 General Electric GE | -1.37% | -114.44% | 🇺🇸 USA |
 ResMed RMD | 26.84% | 182.82% | 🇺🇸 USA |
 Cardinal Health CAH | -0.42% | -104.43% | 🇺🇸 USA |
 Universal Forest Products
UFPI | 9.71% | 2.32% | 🇺🇸 USA |
 CONMED CNMD | -6.77% | -171.34% | 🇺🇸 USA |
 Owens & Minor
OMI | 2.82% | -70.28% | 🇺🇸 USA |
 Philips PHG | -9.70% | -202.21% | 🇳🇱 Netherlands |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.